GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment
- 25 November 2023
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 93, 102134
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
- Majmaah University (R-2023-845)
- Indian Council of Medical Research (45/14/2020/PHA/BMS)
- Indian Council of Medical Research (201900031405)
- Indian Council of Medical Research (DST/INSPIRE/03/2019/001769)
- Indian Council of Medical Research (36/9/2020-Toxi/BMS)
This publication has 161 references indexed in Scilit:
- Brain homogenates from human tauopathies induce tau inclusions in mouse brainProceedings of the National Academy of Sciences, 2013
- Astrocytes from familial and sporadic ALS patients are toxic to motor neuronsNature Biotechnology, 2011
- Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetesClinical Science, 2010
- Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal TransductionJournal of Biological Chemistry, 2010
- Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacyEPMA Journal, 2010
- Transmission and spreading of tauopathy in transgenic mouse brainNature Cell Biology, 2009
- Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's diseaseBrain Research, 2008
- Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cellsExperimental Eye Research, 2007
- Calcium-dependent and -independent interactions of the S100 protein familyBiochemical Journal, 2006
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003